Cargando…

More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization

Norovirus causes acute and debilitating gastroenteritis, characterized by vomiting and diarrhea. We recently reported a recombinant GII. 4 P domain particle (Pd) vaccine adjuvanted with a flagellin, Vibrio vulnificus FlaB, effectively promoting both humoral and cell-mediated immune responses. In the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Hye Suk, Puth, Sao, Tan, Wenzhi, Verma, Vivek, Jeong, Kwangjoon, Lee, Shee Eun, Rhee, Joon Haeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183199/ https://www.ncbi.nlm.nih.gov/pubmed/29781755 http://dx.doi.org/10.1080/21645515.2018.1472185

Ejemplares similares

Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB
por: Verma, Vivek, et al.
Publicado: (2016)

The cytochrome d oxidase complex regulated by fexA is an Achilles' heel in the in vivo survival of Vibrio vulnificus
por: Tan, Wenzhi, et al.
Publicado: (2019)

A stealth adhesion factor contributes to Vibrio vulnificus pathogenicity: Flp pili play roles in host invasion, survival in the blood stream and resistance to complement activation
por: Duong-Nu, Tra-My, et al.
Publicado: (2019)

Deimmunization of flagellin for repeated administration as a vaccine adjuvant
por: Khim, Koemchhoy, et al.
Publicado: (2021)

Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model
por: Puth, Sao, et al.
Publicado: (2017)

Molecular characterization of vulnibactin biosynthesis in Vibrio vulnificus indicates the existence of an alternative siderophore
por: Tan, Wenzhi, et al.
Publicado: (2014)

Intranasal immunization with a flagellin-adjuvanted peptide anticancer vaccine prevents tumor development by enhancing specific cytotoxic T lymphocyte response in a mouse model
por: Nguyen, Chung Truong, et al.
Publicado: (2013)

Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity
por: Khim, Koemchhoy, et al.
Publicado: (2023)

Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression
por: Hwang, Hye Suk, et al.
Publicado: (2020)

Sublingual Delivery of Frovatriptan: An Indication of Potential Alternative Route
por: Verma, Hitesh, et al.
Publicado: (2014)

Intramuscular Priming and Intranasal Boosting Induce Strong Genital Immunity Through Secretory IgA in Minipigs Infected with Chlamydia trachomatis
por: Lorenzen, Emma, et al.
Publicado: (2015)

Investigating Prime-Pull Vaccination through a Combination of Parenteral Vaccination and Intranasal Boosting
por: Roces, Carla B., et al.
Publicado: (2019)

Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer
por: Lee, Shee Eun, et al.
Publicado: (2015)

EVIDENCE OF ACTIVE IMMUNITY TO EXPERIMENTAL POLIOMYELITIS OBTAINED BY THE INTRANASAL ROUTE IN MACACUS RHESUS
por: Kramer, S. D., et al.
Publicado: (1938)

Advances in intranasal vaccine delivery: A promising non-invasive route of immunization
por: Kehagia, Eleni, et al.
Publicado: (2023)

A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens
por: Chandrasekar, Shaswath S., et al.
Publicado: (2023)

Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
por: Ciabattini, Annalisa, et al.
Publicado: (2018)

Characterization of the Antigen-Specific CD4(+) T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous Routes
por: Ciabattini, Annalisa, et al.
Publicado: (2015)

Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge
por: Zuo, Zonghui, et al.
Publicado: (2021)

Specific immunotherapy by the sublingual route for respiratory allergy
por: Incorvaia, Cristoforo, et al.
Publicado: (2010)

A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination
por: Sato-Kaneko, Fumi, et al.
Publicado: (2022)

Sublingual nucleotides and immune response to exercise
por: Ostojic, Sergej M, et al.
Publicado: (2012)

Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice
por: Li, Xingxing, et al.
Publicado: (2022)

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
por: Nguyen, Thuy Trang, et al.
Publicado: (2022)

Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates
por: Marcus, Hadar, et al.
Publicado: (2021)

Distribution of Primed T Cells and Antigen-Loaded Antigen Presenting Cells Following Intranasal Immunization in Mice
por: Ciabattini, Annalisa, et al.
Publicado: (2011)

Induction of Tolerance via the Sublingual Route: Mechanisms and Applications
por: Moingeon, Philippe, et al.
Publicado: (2012)

Heterologous Prime-Boost Vaccination with Commercial FMD Vaccines Elicits a Broader Immune Response than Homologous Prime-Boost Vaccination in Pigs
por: Kim, Jaejo, et al.
Publicado: (2023)

Mucosal Immunity and Sublingual Immunotherapy in Respiratory Disorders
por: Bahceciler, Nerin N.
Publicado: (2012)

Sublingual Delivery of Vaccines for the Induction of Mucosal Immunity
por: Shim, Byoung-Shik, et al.
Publicado: (2013)

Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2021)

Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy
por: Christensen, Dennis, et al.
Publicado: (2022)

Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus
por: Pan, Yuting, et al.
Publicado: (2020)

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
por: Chapman, Ros, et al.
Publicado: (2021)

Innate endogenous adjuvants prime to desirable immune responses via mucosal routes
por: Wang, Xiaoguang, et al.
Publicado: (2014)

Sublingual Immunization With an RSV G Glycoprotein Fragment Primes IL-17-Mediated Immunopathology Upon Respiratory Syncytial Virus Infection
por: Cheon, In Su, et al.
Publicado: (2019)

Is premedication with midazolam more effective by the sublingual than the oral route?
por: Gupta, Shobhana, et al.
Publicado: (2011)

How the Interval between Prime and Boost Injection Affects the Immune Response in a Computational Model of the Immune System
por: Castiglione, F., et al.
Publicado: (2012)

Heterologous Systemic Prime–Intranasal Boosting Using a Spore SARS-CoV-2 Vaccine Confers Mucosal Immunity and Cross-Reactive Antibodies in Mice as well as Protection in Hamsters
por: Katsande, Paidamoyo M., et al.
Publicado: (2022)

Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein
por: Luo, Jian, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_b06v1lveqnkhvm9qti4jkcds4v